ACA
ABMD

Atlas Capital Advisors’s Abiomed Inc ABMD Stock Holding History

Atlas Capital Advisors’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-80
Closed -$19.8K – 1026
2022
Q2 		$19.8K Hold
80
– – ﹤0.01% 688
2022
Q1 		$26.5K Hold
80
– – ﹤0.01% 609
2021
Q4 		$28.7K Hold
80
– – ﹤0.01% 597
2021
Q3 		$26K Hold
80
– – ﹤0.01% 608
2021
Q2 		$25K Sell
80
-47
-37% -$14.4K ﹤0.01% 625
2021
Q1 		$40.5K Buy
127
+25
+25% +$8K 0.01% 516
2020
Q4 		$33.1K Sell
102
-960
-90% -$266K 0.01% 502
2020
Q3 		$294K Buy
+1,062
New +$306K 0.07% 255

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return

Atlas Capital Advisors's ABMD Position: Q3 2022 in Review

Atlas Capital Advisors sold out of Abiomed Inc (ABMD) in Q3 2022, closing a stake of 80 shares — an estimated $19.8K sold.

Atlas Capital Advisors first reported a position in ABMD in Q3 2020 and held it in 8 quarters. The position peaked at $294K in Q3 2020. 517 funds tracked by Wall St. Rank hold ABMD as of Q3 2022.

  • Atlas Capital Advisors reported no remaining Abiomed Inc position as of Q3 2022 after selling out during the quarter.
  • Atlas Capital Advisors sold 80 Abiomed Inc shares in Q3 2022, an estimated $19.8K.
  • Atlas Capital Advisors first reported a position in Abiomed Inc in Q3 2020 and held it in 8 quarters.
  • Atlas Capital Advisors's Abiomed Inc position peaked at $294K in Q3 2020.
  • 517 funds tracked by Wall St. Rank held Abiomed Inc as of Q3 2022.

Based on Atlas Capital Advisors's 13F filing for Q3 2022, filed 8 Nov 2022.